Health Care · Wholesale-Drugs, Proprietaries & Druggists' Sundries

MCK McKesson Corporation SEC Filings & Insider Trading Activity 2026

company
CIK 92765395 filings
S&P 500

MCK at a glance

McKesson Corporation (MCK, SEC CIK 927653) filed its latest 10-K annual report on May 8, 2026, a 10-Q quarterly report on August 5, 2026, an 8-K current report on October 6, 2026 and Form 4 insider filings as recently as September 10, 2026. SignalX summarizes each filing with AI and tracks the company's insider trades and institutional holders.

  • For the fiscal year ended March 31, 2026 (FY2026), McKesson Corporation (MCK) reported revenue of $403.4 billion (up 12.4% from FY2025) and net income of $4.8 billion. Diluted EPS was $38.38.
  • As of June 30, 2026, 57 institutional investment managers tracked by SignalX reported holding McKesson Corporation (MCK) shares worth $38.2 billion in 13F-HR filings.
  • The most recent insider open-market sale reported on Form 4 was by Rutledge Napoleon B JR on September 8, 2026 of 111 shares at $891.45 per share.
  • In the last 90 days, MCK insiders reported 0 open-market purchases ($0) and 2 open-market sales ($368K) on Form 4, a net sale of $368K.

Source: SEC EDGAR (XBRL financial data, 13F-HR and Form 4 filings).

Revenue · FY2026
$403.4B
+12.4% vs prior year
Insiders · 90 days
0 buys · 2 sells
Net −$368K
13F holders
57 funds
$38.2B · −1 vs prior quarter
Latest 8-K
Aug 28, 2026
Item 7.01

AI 10-Q Quarterly Report Analysis

Latest 10-Q, quarter ended Jun 30, 2026

Management Discussion & Analysis

  • Revenue, profitability, segment performance, cash flow, and capital deployment figures not provided
  • Near-term outlook, guidance, and emerging headwinds not included

Risk Factors

  • No risk-factors section provided; excerpt begins with Item 2 on share repurchases
  • Capital-allocation risk: $5.0 billion additional repurchase authorization approved in April 2026
  • Liquidity risk: $5.175 billion remaining repurchase authorization as of June 30, 2026
  • Compliance risk: $25 million excise taxes incurred on share repurchases
  • Execution risk: May 2026 ASR share estimates subject to final settlement in fiscal Q2 2027

AI summary of the MCK 10-Q filed . Generated from the filing text; verify against the original.View on SEC EDGAR10-K vs 10-Q vs 8-K

AI 8-K Current Report Analysis

The most recent material events, by 8-K item

Filed Aug 28, 2026Full analysis →

Item 7.01: Regulation FD Disclosure

  • Cybersecurity incident discovered August 25, 2026, affecting McKesson information systems
  • Investigation remains in early stages, creating ongoing uncertainty around scope and operational impact
Filed Aug 5, 2026Full analysis →

Item 2.02: Results of Operations and Financial Condition

  • Preliminary results cover quarter ended June 30, 2026
  • Exhibit 99.1 contains McKesson’s reported operating and financial results

Item EX-99.1: Item EX-99.1

  • Q1 FY27 revenue $105.4B, up 8%; adjusted EPS $9.93, up 20%, showing strong operating momentum
  • Full-year adjusted EPS guidance raised to $44.20–$45.00 from $43.80–$44.60, implying 13%–15% growth

AI summaries of MCK 8-K current reports filed with the SEC. What 8-K item codes mean

SignalX for MCK

Don't miss the next MCK filing

  • Alerts as it files. A push when MCK files an 8-K or an insider trades.
  • Fund moves. Which tracked funds opened, added or cut MCK, by share count.
  • Ask anything. An AI agent that reads every MCK filing and answers with sources.

MCK alerts on your phone. Follow it in the SignalX Android app.

Get it on Google Play

Recent Insider Transactions (Form 4)

Latest reported trades by officers, directors and 10% owners

InsiderTypeDatePrice
Rutledge Napoleon B JRSellSep 8, 2026$891.45
Lerman Bradley ESellAug 10, 2026$892.33
Srinivasan Ramesh (NMN)AAug 7, 2026-
OZAN KEVIN MAJul 22, 2026-
Martinez MariaAJul 22, 2026$814.04
Lerman Bradley EAJul 22, 2026-
Dunbar Webster RoyAJul 22, 2026-
Hinton James H.AJul 22, 2026-

Financial Summary
XBRL

Annual financial summary from SEC XBRL data
MetricFY2024FY2025FY2026
Profitability
Revenue-$359.1B$403.4B
Gross Profit-$13.3B$14.6B
Operating Income-$4.4B$6.2B
Net Income-$3.3B$4.8B
Gross Margin-3.7%3.6%
Op. Margin-1.2%1.5%
Net Margin-0.9%1.2%
Balance Sheet
Total Assets$67.4B$75.1B$82.3B
Equity--$2.1B-$2.2B
ROE--158.9%-219.2%
Per Share
EPS-$25.72$38.38
Cash Flow
Operating CF-$6.1B$6.2B
CapEx$431.0M$537.0M$436.0M

Source: XBRL data in McKesson Corporation (MCK)'s 10-K filings on SEC EDGAR, in USD. Compare across companies →

13F Fund Holdings: Quarterly Trend

Latest: Q2 2026

Aggregate MCK share value held by 13F filers tracked by SignalX, by quarter.

Quarterly totals table
MCK shares held by 13F filers tracked by SignalX, by quarter
QuarterFundsTotal value
Q2 202657$38.20B
Q1 202658$44.80B
Q4 202555$40.00B
Q3 202554$41.74B
Q2 202552$38.28B
Q1 202550$26.30B
Q4 202443$17.84B
Q3 202439$8.14B
Position changes: Q1 2026 → Q2 2026
Top Buyers
Top Sellers
New Positions
None this quarter.
Closed Positions

Source: 13F-HR filings on SEC EDGAR (aggregated from 408 fund-quarter rows). Reflects only 13F filers tracked by SignalX, not the full institutional ownership universe. How 13F filings work

MCK filing archive

AI analysis pages for each 10-K, 10-Q and 8-K

Latest 2026 SEC Filings: 10-K, 10-Q, 8-K & Form 4

FormFiling dateAnalysisSEC
8-KOct 6, 2026--
4Sep 10, 2026--
8-KAug 28, 2026Analysis-
4Aug 11, 2026--
4Aug 11, 2026--
10-QAug 5, 2026Analysis
8-KAug 5, 2026Analysis-
8-KJul 24, 2026Analysis-
4Jul 23, 2026--
4Jul 23, 2026--
4Jul 23, 2026--
4Jul 23, 2026--
4Jul 23, 2026--
4Jul 23, 2026--
4Jul 23, 2026--
4Jul 23, 2026--
4Jul 23, 2026--
4Jul 23, 2026--
4Jul 8, 2026--
8-KJul 1, 2026Analysis-
4Jun 18, 2026--
8-KJun 12, 2026Analysis-
4Jun 11, 2026--
4Jun 8, 2026-
4Jun 1, 2026-

Related Health Care companies

All Health Care →

MCK SEC filings: frequently asked questions

Are MCK insiders buying or selling?

In the last 90 days, McKesson Corporation (MCK) officers, directors and 10% owners reported no open-market purchases and 2 open-market sales worth $367,541 by 2 insiders on Form 4. Many insider sales are pre-planned or for taxes, so purchases usually carry more information.

Which institutions hold MCK stock?

As of June 30, 2026, the largest McKesson Corporation (MCK) holders among the 13F filers tracked by SignalX were BlackRock ($8.2 billion), Vanguard Capital Management LLC ($5.9 billion), State Street Corp ($4.3 billion), Morgan Stanley ($4.0 billion), Franklin Resources ($2.2 billion). 13F-HR reports are filed up to 45 days after each quarter ends.

What was MCK's revenue in fiscal year 2026?

For the fiscal year ended March 31, 2026 (FY2026), McKesson Corporation (MCK) reported revenue of $403.4 billion (up 12.4% from FY2025) and net income of $4.8 billion. Diluted EPS was $38.38. The figures come from the XBRL data in the 10-K.

What did MCK report in its latest 8-K?

McKesson Corporation (MCK) filed an 8-K on August 28, 2026 reporting Item 7.01 (Regulation FD Disclosure). Cybersecurity incident discovered August 25, 2026, affecting McKesson information systems.

What are the latest MCK SEC filings?

McKesson Corporation (MCK) filed its latest 10-K annual report on May 8, 2026, a 10-Q quarterly report on August 5, 2026, an 8-K current report on October 6, 2026 and a Form 4 insider filing on September 10, 2026.

What is MCK's SEC CIK number?

McKesson Corporation (MCK)'s SEC Central Index Key (CIK) is 927653. EDGAR lists every MCK filing under that number.

Ask anything about MCK

The research agent reads MCK's filings, financials, insider trades and 13F holders, then answers with sources.